EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery

Julian M Ivanov iD, Rumiana Tenchov iD, Krittika Ralhan, Kavita A Iyer, Shivangi Agarwal, Qiongqiong Angela Zhou iD

Journal of Chemical Information and Modeling · 2024

DOI: 10.1021/acs.jcim.4c00864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2024. Verfasst von Julian M Ivanov und 5 weiteren Autor:innen. Beteiligte Einrichtung: CAS, A Division of the American Chemical Society, Columbus, Ohio 43210, United States. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Quantitative Structure-Activity Relationship, Protein Kinase Inhibitors, Drug Discovery. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TBK1, or TANK-binding kinase 1, is an enzyme that functions as a serine/threonine protein kinase. It plays a crucial role in various cellular processes, including the innate immune response to viruses, cell proliferation, apoptosis, autophagy, and antitumor immunity. Dysregulation of TBK1 activity can lead to autoimmune diseases, neurodegenerative disorders, and cancer. Due to its central role in these critical pathways, TBK1 is a significant focus of research for therapeutic drug development. In this paper, we explore data from the CAS Content Collection regarding TBK1 and its implication in a large assortment of diseases and disorders. With the demand for developing efficient TBK1 inhibitors being outlined, we focus on utilizing a machine learning approach for developing predictive models for TBK1 inhibition, derived from the fragment-functional analysis descriptors. Using the extensive CAS Content Collection, we assembled a training set of TBK1 inhibitors with experimentally measured IC50 values. We explored several machine learning techniques combined with various molecular descriptors to derive and select the best TBK1 inhibitor QSAR models. Certain significant structural alerts that potentially contribute to inhibition of TBK1 are outlined and discussed. The merit of the article stems from identifying the most adequate TBK1 QSAR models and subsequent successful development of advanced positive training data to facilitate and enhance drug discovery for an important therapeutic target such as TBK1 inhibitors, based on an extensive, wide-ranging set of scientific information provided by the CAS Content Collection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesQuantitative Structure-Activity RelationshipProtein Kinase InhibitorsDrug DiscoveryMachine LearningHumansComputer SimulationModels, Molecular

Substanzen

Protein Serine-Threonine KinasesProtein Kinase InhibitorsTBK1 protein, human

Autor:innen und Institutionen

  • CAS, A Division of the American Chemical Society, Columbus, Ohio 43210, United States.
  • ACS International India Pvt. Ltd., Pune 411044, India.

ORCID-Profile: Julian M Ivanov, Rumiana Tenchov, Qiongqiong Angela Zhou

Zitieren

APA

Ivanov, J. M., Tenchov, R., Ralhan, K., Iyer, K. A., Agarwal, S., & Zhou, Q. A. (2024). In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.4c00864

Vancouver

Ivanov JM, Tenchov R, Ralhan K, Iyer KA, Agarwal S, Zhou QA. In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery. Journal of Chemical Information and Modeling. 2024. doi:10.1021/acs.jcim.4c00864

BibTeX
@article{Ivanov2024,
  author = {Ivanov, Julian M and Tenchov, Rumiana and Ralhan, Krittika and Iyer, Kavita A and Agarwal, Shivangi and Zhou, Qiongqiong Angela},
  title = {In Silico Insights: QSAR Modeling of TBK1 Kinase Inhibitors for Enhanced Drug Discovery},
  journal = {Journal of Chemical Information and Modeling},
  year = {2024},
  doi = {10.1021/acs.jcim.4c00864}
}
Kostenlos starten →